Lowering LDL-C And Controlling Elevated Blood Pressure And Lipoprotein Little A [Lp(a)] Can Lower Cardiovascular Risk 80%: What To Do If Patients Can't Tolerate A Statin Dose: Ezetimibe (Zetia), A PCSK9 Inhibitor, Inclisiran, Bempedoic Acid (Nexletol), Etc.

Current Optimal Antiplatelet And Anticoagulation Treatment For Various Vascular Procedures In Various Vascular Beds: What Newer Drugs And DOACs Are Useful And What Is The Optimal Timing Of Treatment

Update On Autologous Cell And Gene Therapy For Chronic Limb Threatening Ischemia (CLTI): Do They Really Work And Future Prospects

Why A New Oral PCSK9 Inhibitor (AZD0780) Will Be A Game Changer In Lipid Management And Lowering The Morbidity Of Atherosclerosis: Implications Of Its Different Mode Of Action

New Uses For The WavelinQ EndoAVF Device: Turning Veins Into Arteries: How It Can Be Used To Treat CLTI And ESRD: How Does It Work And Clinical Experience

Optimal Current Management Of Takayasu's Disease Involving The Supra-Aortic Branches: Technical Details For Open Surgical Management And What Is The Role For Endo Treatment With Bare Or Covered Stents In 2025

Twenty Years Of Large Blood Vessel Management In The Treatment Of Retroperitoneal Sarcomas: Lessons Learned And Why A Vascular Surgeon Is Critical To Successful Treatment

Nutritional Science: How Can It Transform Peripheral Arterial Disease Outcomes

Panel Discussion